282 Letters in Organic Chemistry, 2010, Vol. 7, No. 4
Kefayati et al.
Spiro[5.3ꢀ]-1ꢀ-N-Methyl-oxindole-5,6-dihydropyrimido[4,5-d]pyri-
midine-2,4,7-(1H,3H,8H)-trione (4f): Mp 228-230 ˚C; IR (KBr)
2H, CH2), 6.75-7.20 (m, 4H, H-aromatic), 7.93 (s, 1H, NH), 10.25
(s, 1H, NH). 13C NMR (75 MHz, DMSO-d6) ꢂ: 13.8, 17.3, 30.2,
60.2, 62.8, 101.0, 110.3, 122.5, 124.1, 129.9, 134.4, 143.0, 151.7,
152.3, 165.8, 178.0 ppm; MS (70 eV): m/z (%): 315 (16, M+), 286
(90), 242 (100), 214 (35), 199 (13), 103 (9), 91 (7), 77 (9), 56 (70),
42 (8).
5ꢀ-Bromo-spiro[4.3']oxindole-ethyl-1,2,3,4-tetrahydro-1,6-dimethyl-
2-oxo-pyrimidine-5-carboxylate (8d): Mp 175-178 ˚C; IR (KBr)
(ꢁmax cm-1): 3452, 3217, 1740, 1712, 1649. 1H NMR (300 MHz,
DMSO-d6) ꢂ: 0.64 (t, 3H, CH3), 2.27 (s, 3H, CH3), 3.01 (s, 3H,
CH3), 3.59 (m, 2H, CH2), 6.46-7.13 (m, 3H, H-aromatic), 7.29 (s,
1H, NH), 9.80 (s, 1H, NH). 13C NMR (75 MHz, DMSO-d6) ꢂ: 13.5,
14.4, 17.3, 60.3, 63.0, 100.2, 111.8, 114.5, 126.9, 132.2, 135.9,
141.3, 151.9, 152.0, 165.3, 177.9 ppm. MS (70 eV): m/z (%): 393
(6, M+), 364 (40), 320 (38), 292 (12), 277 (8), 103(8), 91 (7), 77
(7), 56 (100), 42 (15).
1
(ꢁmax cm-1): 3380, 3184, 3097, 2981, 1740, 1710, 1690; H NMR
(300 MHz, DMSO-d6) ꢂ: 3.03 (s, 3H, CH3), 6.91-7.28 (m, 4H, H-
aromatic), 11.2 (m, 4H, NH); 13C NMR (75 MHz, DMSO-d6) ꢂ:
53.5, 56.9, 109.2, 123.0, 124.7, 128.4, 129.8, 145.4, 151.0, 168.6,
175.1 ppm.
5ꢀ-Bromo-spiro[5,3ꢀ]oxindole-5,6-dihydropyrimido[4,5-d]pyrimi-
dine-2,4,7-(1H,3H,8H)- trione (4g): Mp 238-240 ˚C; IR (KBr) (ꢁmax
cm-1): 3334, 3211, 3093, 1731, 1689; 1H NMR (300 MHz, DMSO-
d6) ꢂ: 6.68-7.35 (m, 3H, H-aromatic), 10.74 (s, 1H, NH), 11.25 (m,
4H, NH); 13C NMR (75 MHz, DMSO-d6) ꢂ: 56.9, 112.1, 113.8,
128.1, 131.6, 132.3, 143.6, 151.0, 168.0, 176.3 ppm.
5ꢀ-Bromo-spiro[5,3ꢀ]oxindole-5,6,7,8-tetrahydro-7-thioxopyrimido
[4,5-d]pyrimidine-2,4-(1H,3H)-dione (4h): Mp 365-367 ˚C; IR
(KBr) (ꢁmax cm-1): 3328, 3151, 3098, 1710, 1681; 1H NMR (300
MHz, DMSO-d6) ꢂ: 6.73-8.27 (m, 3H, H-aromatic), 10.63 (s, 1H,
NH), 11.20 (m, 2H, NH), 11.32 (m, 2H, NH); 13C NMR (75 MHz,
DMSO-d6) ꢂ: 57.3, 112.8, 112.9, 128.6, 132.1, 132.7, 143.9, 168.3,
176.7, 178.1 ppm.
Kappe, C.O. A reexamination of the mechanism of the Biginelli
dihydropyrimidine synthesis. Support for an N-acyliminium ion
intermediate. J. Org. Chem. 1997, 62, 7201.
General procedure for the synthesis of spiro[oxindole-
pyrrimidine]ones 8a-i: A mixture of isatin derivative 1 (5 mmol),
acyclic 1,3-dicarbonyl compound 7 (7.5 mmol), urea or N-methyl
urea or thiourea 3 (10 mmol), HCl (15% mmol) and ethanol (5 mL)
refluxed for appropriate time according to Table 3 (Scheme 4). The
reaction after completion, as monitored by TLC on silica gel using
ethyl acetate as eluent, was allowed to cool to room temperature.
Then 30 mL distilled water was added to the beaker and stirred for
10 minute. The precipitate thus obtained was filtered off. The crude
product was purified by recrystallization from ethanol 95.5% and
dried.
Spiro[4.3']oxindole-ethyl-1,2,3,4-tetrahydro-6-methyl-2-oxo-pyri-
midine-5-carboxylate (8a): Mp 297-299 ˚C; IR (KBr) (ꢁmax cm-1):
3436, 3201, 3089, 2970, 1716, 1664; 1H NMR (300 MHz, DMSO-
d6) ꢂ: 0.80 (t, 3H, CH3 ), 2.44 (s, 3H, CH3), 3.72 (m, 2H, CH2),
6.75-7.19 (m, 4H, H-aromatic), 7.80 (s, 1H, NH), 9.37 (s, 1H, NH),
10.23 (s, 1H, NH); 13C NMR (75 MHz, DMSO-d6) ꢂ: 14.0, 19.0,
19.4, 63.9, 97.86, 110.2, 122.5, 124.1, 129.7, 135.1, 143.0, 150.8,
151.3, 165.4, 178.2 ppm; MS (70 eV): m/z (%): 301 (10, M+), 272
(64), 228 (100), 200 (34), 131 (7), 103 (10), 91 (8), 77 (8), 56 (7),
42 (17). Anal. Calcd. for C15H15N3O4: C, 59.79; H, 5.02; N, 13.95.
Found: C, 59.85; H, 4.86; N, 14.00.
Spiro[4.3']oxindole-N-Phenyl-1,2,3,4-tetrahydro-6-methyl-2-oxo-
pyrimidine-5-carboxamide (8e): Mp 298-300 ˚C; IR (KBr) (ꢁmax
1
cm-1): 3400, 3298, 1722, 1700. H NMR (300 MHz, DMSO-d6) ꢂ:
2.01 (s, 3H, CH3), 6.69-7.38 (m, 9H, H-aromatic), 7.56 (s, 1H,
NH), 8.92 (s, 1H, NH), 9.69 (s, 1H, NH), 10.13 (s, 1H, NH). 13C
NMR (75 MHz, DMSO-d6) ꢂ: 18.3, 64.2, 105.3, 110.3, 120.0,
122.3, 123.9, 124.7, 129.3, 133.2, 139.7, 139.8, 143.3, 152.8,
165.0, 178.3 ppm. Anal. Calcd. for C19H16N4O3: C, 65.51; H, 4.63;
N, 16.08. Found: C, 65.46; H, 4.55; N, 16.12.
[33]
[34]
Spiro[4.3']oxindole-N-Phenyl-1,2,3,4-tetrahydro-1,6-dimethyl-2-
oxo-pyrimidine-5-carboxamide (8f): Mp 265-268 ˚C; IR (KBr)
1
(ꢁmax cm-1): 3410, 3298, 1718, 1700. H NMR (300 MHz, DMSO-
d6) ꢂ: 2.16 (s, 3H, CH3), 3.15 (s, 3H, CH3), 6.69-7.36 (m, 9H, H-
aromatic), 7.72 (s, 1H, NH), 9.91 (s, 1H, NH), 10.16 (s, 1H, NH).
13C NMR (75 MHz, DMSO-d6) ꢂ: 18.3, 30.0, 63.1, 107.8, 110.3,
120.2, 122.3, 124.0, 125.0, 129.3, 130.0, 132.4, 139.6, 140.5,
143.2, 153.6, 165.3, 178.0 ppm.
5ꢀ-Bromo-spiro[4.3']oxindole-N-Phenyl-1,2,3,4-tetrahydro-6-met-
hyl-2-oxo-pyrimidine-5-carboxamide (8g): Mp 295-297 ˚C; IR
(KBr) (ꢁmax cm-1): 3405, 3220, 1712, 1690. 1H NMR (300 MHz,
DMSO-d6) ꢂ: 2.02 (s, 3H, CH3), 6.67-7.39 (m , 8H, H-aromatic),
7.67 (s, 1H, NH), 9.01 (s, 1H, NH), 9.74 (s, 1H, NH), 10.30 (s, 1H,
NH). 13C NMR (75 MHz, DMSO-d6) ꢂ: 18.4, 64.3, 104.6, 112.3,
113.7, 120.0, 120.2, 124.0, 127.5, 129.4, 132.6, 135.8, 139.6,
140.5, 142.6, 152.5, 164.9, 177.8 ppm.
5ꢀ-Bromo-spiro[4.3']oxindole-ethyl-1,2,3,4-tetrahydro-6-methyl-2-
thio-pyrimidine-5-carboxylate (8h): Mp 323-325 ˚C; IR (KBr) (ꢁmax
cm-1): 3407, 3315, 3132, 1715, 1709; 1H NMR (300 MHz, DMSO-
d6) ꢂ: 0.88 (t, 3H, CH3), 2.35 (s, 3H, CH3), 3.78 (m, 2H, CH2),
6.46-7.13 (m, 3H, H-aromatic), 7.76 (s, 1H, NH), 9.54 (s, 1H, NH),
10.48 (s, 1H, NH); 13C NMR (75 MHz, DMSO-d6) ꢂ: 15.1, 20.4,
20.9, 69.7, 100.6, 114.1, 115.8, 127.6, 132.1, 141.9, 151.3, 165.4,
174.7, 178.1 ppm.
5ꢀ-Bromo-spiro[4.3']oxindole-ethyl-1,2,3,4-tetrahydro-6-methyl-2-
oxo-pyrimidine-5-carboxylate (8b): Mp 293-295 ˚C; IR (KBr) (ꢁmax
1
cm-1): 3420, 3310, 3145, 1730, 1705, 1640; H NMR (300 MHz,
DMSO-d6) ꢂ: 0.85 (t, 3H, CH3), 2.24 (s, 3H, CH3), 3.76 (m, 2H,
CH2), 6.71-7.37 (m, 3H, H-aromatic), 7.87 (s, 1H, NH), 9.44 (s,
1H, NH), 10.39 (s, 1H, NH); 13C NMR (75 MHz, DMSO-d6) ꢂ:
14.0, 19.0, 19.1, 64.0, 97.0, 112.2, 113.9, 126.9, 132.4, 142.3,
151.0, 151.7, 165.2, 177.9 ppm; MS (70 eV): m/z (%): 379 (14,
M+), 350 (75), 306 (100), 278 (19), 263 (12), 210 (11), 131 (12),
103 (14), 91 (10), 77 (9), 42 (43).
Spiro[4.3']oxindole-ethyl-1,2,3,4-tetrahydro-1,6-dimethyl-2-oxo-
pyrimidine-5-arboxylate (8c): Mp 248-250 ˚C; IR (KBr) (ꢁmax cm-
1): 3320, 3259, 1735, 1710, 1664; 1H NMR (300 MHz, DMSO-d6)
ꢂ: 0.78 (t, 3H, CH3), 2.43 (s, 3H, CH3), 3.17 (s, 3H, CH3), 3.69 (m,
Spiro[4.3']oxindole-N-Phenyl-1,2,3,4-tetrahydro-6-methyl-2-thio-
pyrimidine-5-carboxamide (8i): Mp 331-333 ˚C; IR (KBr) (ꢁmax
1
cm-1): 3408, 3301, 1718, 1703. H NMR (300 MHz, DMSO-d6) ꢂ:
2.08 (s, 3H, CH3), 6.72-7.43 (m, 9H, H-aromatic), 7.50 (s, 1H,
NH), 9.01 (s, 1H, NH), 9.73 (s, 1H, NH), 10.53 (s, 1H, NH). 13C
NMR (75 MHz, DMSO-d6) ꢂ: 19.3, 64.8, 106.3, 111.2, 119.8,
122.7, 124.1, 124.9, 130.2, 133.1, 139.9, 140.0, 143.9, 165.9,
175.6, 177.1 ppm.